COL1A2 and metabolic dysfunction-associated steatohepatitis: In contrast, the expression of Col1a1, Col1a2, Col3a1, Col4a5, Col6a1, Col6a2, Col8a1, Col14a1, Col15a1 and Fbn1 in hepatic LyECs was decreased during NASH compared with normal conditions (Figure S6B).